AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
CRISPR Breakthroughs in Biotechnology
This chapter explores the FDA's groundbreaking approval of the first CRISPR-based medication for sickle cell disease, detailing the evolution of genome editing technologies. It discusses the challenges of current treatments and the promising advancements in gene therapies aimed at achieving affordable solutions for chronic illnesses. Additionally, the chapter highlights the significant progress in CRISPR applications in vaccines and other diseases, ushering in a new era of medical innovation.